The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 391 through 400 of 882 results (Download Results)

Show results per page

Supporting mental health and preventing moral injury among long term care+ workers: A mixed methods tool kit development and implementation study

Lashewicz, Bonnie M | The University of Calgary | Operating Grant | $149,855

CIHR Alberta 2020

Peginterferon lambda to treat outpatients with COVID‑19 to prevent severe disease: Focus on variants of concern

Feld, Jordan J | University Health Network | Operating Grant | $994,420

CIHR Ontario 2021

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

Newman, Peter A | University of Toronto | Operating Grant | $374,314

CIHR Ontario 2021

The COVENANT Study: COVID‑19 Cohort Study of People Experiencing Homelessness in Toronto

Hwang, Stephen W | Unity Health Toronto | Operating Grant | $1,901,698

CIHR Ontario 2020

COVID-19 Variant Supplement – Evaluating the differential impact of what we have done, as we prioritize what to do next: a multi-provincial intervention modeling study using population-based data

Mishra, Sharmistha | St. Michael's Hospital | Operating Grant | $50,000

CIHR Ontario 2021

The Canadian Respiratory Research Network Long COVID‑19 Study

Gershon, Andrea S | Sunnybrook Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

CATCO Scale-Up COVID‑19 Supplement – Canadian Treatments for COVID-19: SOLIDARITY

Murthy, Srinivas | University of British Columbia | Operating Grant | $3,500,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

Rini, James M | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Cellular Immuno-Therapy for COVID‑19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial

Stewart, Duncan J | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Moitessier, Nicolas R | McGill University | Operating Grant | $50,000

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Supporting mental health and preventing moral injury among long term care+ workers: A mixed methods tool kit development and implementation study

Peginterferon lambda to treat outpatients with COVID‑19 to prevent severe disease: Focus on variants of concern

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

The COVENANT Study: COVID‑19 Cohort Study of People Experiencing Homelessness in Toronto

COVID-19 Variant Supplement – Evaluating the differential impact of what we have done, as we prioritize what to do next: a multi-provincial intervention modeling study using population-based data

The Canadian Respiratory Research Network Long COVID‑19 Study

CATCO Scale-Up COVID‑19 Supplement – Canadian Treatments for COVID-19: SOLIDARITY

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

COVID-19 Variant Supplement – Cellular Immuno-Therapy for COVID‑19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.